MC
MPM Capital
Venture CapitalActiveMPM Capital caters to the healthcare sector with seed, early, and later stage ventures, and private equity investments.
223
Investments
10
Exits
$1.5B
AUM
4.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for MPM Capital.
Investment Thesis & Strategy
MPM Capital invests in seed, early, and later-stage biotech, healthcare, and life science companies, as well as private equity opportunities. They seek to invest in ventures within the healthcare sector.
Notable Exits
CompanyTypeYearValue / Acquirer
Turning Point TherapeuticsAcquisition2022$4.1B
iTeos TherapeuticsIPO2021—
Revolution MedicinesIPO2020—
Harpoon TherapeuticsIPO2019—
Gossamer BioIPO2019—
Surface OncologyIPO2018—
Adaptimmune TherapeuticsIPO2015—
Radius HealthIPO2014—
bluebird bioIPO2013—
EpizymeIPO2013—
Frequently Asked Questions
MPM Capital focuses on Series A, Series B, Series C+ stage investments.
Related Investors
General Catalyst
Cambridge, United States · 737 deals
Atlas Venture
Cambridge, United States · 514 deals
F-Prime Capital
Cambridge, United States · 228 deals
Accomplice
Cambridge, United States · 222 deals
Flagship Pioneering
Cambridge, United States · 213 deals
CVP Management
Cambridge, United States · 149 deals